Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edward Schnipper"'
Autor:
Tina Van Geen Hoven, Daniel D. Von Hoff, Kevin McDonnell, Allen Horhota, James Wright, Erick Peeke, Jason Auer, Stephen E. Zale, Abhimanyu Sabnis, Jason Summa, Michael Figa, Young-Ho Song, Mir Mukkaram Ali, David De Witt, Greg Troiano, Edward Schnipper, Jeffrey J. Song, Susan Low, Omid C. Farokhzad, Beadle Retnarajan, Tarikh Christopher Campbell, Douglas Tompsett, Elizaveta Andrianova, Christopher Sweeney, Jeffrey S. Hrkach, Neil H. Bander, Philip W. Kantoff, Robert Langer, Maria Figueiredo, Patricia LoRusso
Publikováno v:
Science Translational Medicine. 4
We describe the development and clinical translation of a targeted polymeric nanoparticle (TNP) containing the chemotherapeutic docetaxel (DTXL) for the treatment of patients with solid tumors. DTXL-TNP is targeted to prostate-specific membrane antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c85941643a30b753208cbff2d3524e9
https://doi.org/10.1126/scitranslmed.3003651
https://doi.org/10.1126/scitranslmed.3003651
Autor:
Margaret Tonda, David I. Rosenthal, Li Liu, Randal S. Weber, Gregory S. Weinstein, Kenneth Rockwell, Sue S. Yom, Edward Schnipper, Kenneth M. Algazy, Ara A. Chalian, Diane Hershock, Mitchell Machtay, Linda Miller
Publikováno v:
Investigational new drugs. 20(3)
Background: Liposomal cisplatinpreparations have two potential advantagesover the free drug when combined withradiation therapy (RT): 1) selective tumorlocalization, improving the therapeuticratio, and 2) prolonged half-life, allowingmore radiosensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef2543c0edf9c48e406c7ed4e2a87a7
https://pubmed.ncbi.nlm.nih.gov/12201498
https://pubmed.ncbi.nlm.nih.gov/12201498
Autor:
James M. Reuben, Edward Schnipper, Jorge R. Quesada, John T. Manning, Loretta M. Itri, Michael J. Keating, Jordan U. Gutterman, Evan M. Hersh
Publikováno v:
Blood. 68:493-497
Thirty patients with hairy cell leukemia were treated with recombinant interferon alpha-A (rIFN alpha A; Roferon-A); seven were previously untreated. Nine complete and 17 partial remissions were documented by bone marrow core biopsies. All patients'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::762cc3d070379cec10d5bfa09293a594
https://doi.org/10.1182/blood.v68.2.493.493
https://doi.org/10.1182/blood.v68.2.493.493